EUVIMEDEUVIMED entdecken
Crossref

Evaluation of plan quality, safety, and toxicity of brachytherapy for locally advanced cervical cancer in an Australian setting following changes in prescription and applicator design

Emily Flower iD, Gemma Busuttil, Eireann Cosgriff, Niluja Thiruthaneeswaran, Salman Zanjani, Emma Sullivan, Alison Salkeld iD, Jonathan Sykes iD, David Thwaites iD, Jennifer Chard

Journal of Medical Imaging and Radiation Oncology · 2025

DOI: 10.1111/1754-9485.13811 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Imaging and Radiation Oncology, 2025. Verfasst von Emily Flower und 9 weiteren Autor:innen. Beteiligte Einrichtung: Sydney West Radiation Oncology Network, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Brachytherapy, Uterine Cervical Neoplasms, Radiotherapy Planning, Computer-Assisted. Die Arbeit nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Chemoradiotherapy with MRI‐guided brachytherapy boosts is the standard of care for locally advanced cervical cancer. Data from the RetroEMBRACE and EMBRACE I trials provide dose‐response curves for target volumes and OAR. This study evaluated plan quality, safety and toxicity following escalation of the CTV_HR D90 prescription from 80–90 Gy to 85–95 Gy for two different applicator designs.

Methods

A retrospective dosimetric plan quality review was undertaken for consecutively treated locally advanced cervical cancer brachytherapy boosts between 2017 and 2022, and the relationships between implant total reference air kerma (TRAK), CTV_HR volume and vaginal dose were investigated. Safety and ≤grade 3 toxicity results were evaluated.

Results

Seventy patients were identified. All patients received a CTV_HR D90 dose >85 Gy and rectum D2cm 3 of

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrachytherapyUterine Cervical NeoplasmsRadiotherapy Planning, Computer-AssistedHumansFemaleRetrospective StudiesRadiotherapy DosageAustraliaMiddle AgedAgedAdultRadiotherapy, Image-GuidedAged, 80 and overOrgans at Risk

Stichwörter der Autor:innen

applicator designcervical cancer brachytherapyplan quality

Autor:innen und Institutionen

  • Sydney West Radiation Oncology Network, Sydney, New South Wales, Australia.
  • School of Physics, University of Sydney, Sydney, New South Wales, Australia.
  • School of Medicine, University of Sydney, Sydney, New South Wales, Australia.

ORCID-Profile: Emily Flower, Alison Salkeld, Jonathan Sykes, David Thwaites

Zitieren

APA

Flower, E., Busuttil, G., Cosgriff, E., Thiruthaneeswaran, N., Zanjani, S., Sullivan, E., Salkeld, A., Sykes, J., Thwaites, D., & Chard, J. (2025). Evaluation of plan quality, safety, and toxicity of brachytherapy for locally advanced cervical cancer in an Australian setting following changes in prescription and applicator design. Journal of Medical Imaging and Radiation Oncology. https://doi.org/10.1111/1754-9485.13811

Vancouver

Flower E, Busuttil G, Cosgriff E, Thiruthaneeswaran N, Zanjani S, Sullivan E, et al. Evaluation of plan quality, safety, and toxicity of brachytherapy for locally advanced cervical cancer in an Australian setting following changes in prescription and applicator design. Journal of Medical Imaging and Radiation Oncology. 2025. doi:10.1111/1754-9485.13811

BibTeX
@article{Flower2025,
  author = {Flower, Emily and Busuttil, Gemma and Cosgriff, Eireann and Thiruthaneeswaran, Niluja and Zanjani, Salman and Sullivan, Emma and Salkeld, Alison and Sykes, Jonathan and Thwaites, David and Chard, Jennifer},
  title = {Evaluation of plan quality, safety, and toxicity of brachytherapy for locally advanced cervical cancer in an Australian setting following changes in prescription and applicator design},
  journal = {Journal of Medical Imaging and Radiation Oncology},
  year = {2025},
  doi = {10.1111/1754-9485.13811}
}
Kostenlos starten →